# Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma

> **NCT02768389** · EARLY_PHASE1 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 18 (actual)

## Conditions studied

- Glioblastoma
- Brain Tumor

## Interventions

- **DRUG:** Bevacizumab
- **BEHAVIORAL:** Modified Atkins Diet

## Key facts

- **NCT ID:** NCT02768389
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-06
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-03-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02768389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02768389, "Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02768389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*